This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Alauzet C., Lozniewski A., Marchandin H.: Metronidazole resistance and nim genes in anaerobes: A review. Anaerobe, 55, 40–53 (2019)AlauzetC.LozniewskiA.MarchandinH.Metronidazole resistance and nim genes in anaerobes: A review554053201910.1016/j.anaerobe.2018.10.00430316817Search in Google Scholar
Ank N., Sydenham T.V., Iversen L.H., Justesen U.S., Wang M.: Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing. Int. J. Antimicrob. Agents,46, 117–120 (2015)AnkN.SydenhamT.V.IversenL.H.JustesenU.S.WangM.Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing46117120201510.1016/j.ijantimicag.2015.02.02425940770Search in Google Scholar
Baaity Z., Jamal W., Rotimi V.O., Burián K., Leitsch D., Somogyvári F., Nagy E., Sóki J. Molecular characterization of metronidazole resistant Bacteroides strains from Kuwait. Anaerobe, doi: 10.1016/j.anaerobe.2021.102357 (2021)BaaityZ.JamalW.RotimiV.O.BuriánK.LeitschD.SomogyváriF.NagyE.SókiJ.Molecular characterization of metronidazole resistant Bacteroides strains from Kuwait10.1016/j.anaerobe.2021.102357202133713801Open DOISearch in Google Scholar
Brook I.: Bacteraemia due to anaerobic bacteria in newborns. J. Perinatol.10, 351–356 (1991)BrookI.Bacteraemia due to anaerobic bacteria in newborns103513561991Search in Google Scholar
Brook I.: The role of anaerobic bacteria in bacteraemia. Anaerobe, 16, 183–189 (2010)BrookI.The role of anaerobic bacteria in bacteraemia16183189201010.1016/j.anaerobe.2009.12.00120025984Search in Google Scholar
Brook I.: Spectrum and treatment of anaerobic infections. J. Infect. Chemother.22, 1–13 (2016)BrookI.Spectrum and treatment of anaerobic infections22113201610.1016/j.jiac.2015.10.01026620376Search in Google Scholar
Brook I., Wexler H.M., Goldstein E.J.C.: Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing. Clin. Microbiol. Rev.26, 526–546 (2013)BrookI.WexlerH.M.GoldsteinE.J.C.Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing26526546201310.1128/CMR.00086-12371949623824372Search in Google Scholar
Centers for Disease Control and Prevention (CDC): Multidrug-resistant Bacteroides fragilis-Seattle, Washington, 2013. MMWR. Morb. Mortal. Wkly. Rep.62, 694–696 (2013)Centers for Disease Control and Prevention (CDC)Multidrug-resistant Bacteroides fragilis-Seattle, Washington, 2013. MMWR626946962013Search in Google Scholar
Cobo F., Aliaga L., Expósito-Ruiz M., Navarro-Marí J.M.: Anaerobic bacteraemia: A score predicting mortality. Anaerobe, 64, doi: 10.1016/j.anaerobe.2020.102219 (2020)CoboF.AliagaL.Expósito-RuizM.Navarro-MaríJ.M.Anaerobic bacteraemia: A score predicting mortality6410.1016/j.anaerobe.2020.102219202032531433Open DOISearch in Google Scholar
Diniz C.G.: Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J. Antimicrob. Chemother.54, 100–108 (2004)DinizC.G.Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant54100108200410.1093/jac/dkh25615150173Search in Google Scholar
Dumont Y., Bonzon L., Michon A.L., Carriere C., Didelot M.N., Laurens C., Renard B., Veloo A.C.M., Godreuil S., Jean-Pierre H.: Epidemiology and microbiological features of anaerobic bacteraemia in two French University hospitals. Anaerobe, 64, doi: 10.1016/j.anaerobe.2020.102207 (2020)DumontY.BonzonL.MichonA.L.CarriereC.DidelotM.N.LaurensC.RenardB.VelooA.C.M.GodreuilS.Jean-PierreH.Epidemiology and microbiological features of anaerobic bacteraemia in two French University hospitals6410.1016/j.anaerobe.2020.102207202032360436Open DOISearch in Google Scholar
European Committee on Antimicrobial Susceptibility Testing: Clinical breakpoints – breakpoints and guidance v 12.0 January 1, 2022, https://www.eucast.org (01.02.2022)European Committee on Antimicrobial Susceptibility Testinghttps://www.eucast.org (01.02.2022)Search in Google Scholar
Fenner L., Widmer A.F., Straub C., Frei R.: Is the incidence of anaerobic bacteraemia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J. Clin. Microbiol.46, 2432–2434 (2008)FennerL.WidmerA.F.StraubC.FreiR.Is the incidence of anaerobic bacteraemia decreasing? Analysis of 114,000 blood cultures over a ten-year period4624322434200810.1128/JCM.00013-08244694218463219Search in Google Scholar
Finegold S.M., George W.L., Mulligan M.E.: Anaerobic infections part II. Dis. Mon.31, 1–97 (1985)FinegoldS.M.GeorgeW.L.MulliganM.E.Anaerobic infections part II31197198510.1016/0011-5029(85)90027-6Search in Google Scholar
Gajdács M., Urbán E.: Relevance of anaerobic bacteremia in adult patients: A never-ending story? Eur. J. Microbiol. Immunol.5, 64–75 (2020)GajdácsM.UrbánE.Relevance of anaerobic bacteremia in adult patients: A never-ending story?56475202010.1556/1886.2020.00009739137932590337Search in Google Scholar
Gao Q., Wu S., Xu T., Zhao X., Huang H., Hu F.: Emergence of carbapenem resistance in Bacteroides fragilis in China. Int. J. Antimicrob. Agents.53, 859–863, (2019)GaoQ.WuS.XuT.ZhaoX.HuangH.HuF.Emergence of carbapenem resistance in Bacteroides fragilis in China53859863201910.1016/j.ijantimicag.2019.02.01730831235Search in Google Scholar
Genzel G.H., Stubbings W., Stîngu C.S., Labischinski H., Schaumann R.: Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria. Int. J. Antimicrob. Agents.44, 420–423 (2014)GenzelG.H.StubbingsW.StînguC.S.LabischinskiH.SchaumannR.Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria44420423201410.1016/j.ijantimicag.2014.07.00625264128Search in Google Scholar
Grohs P., Mainardi J.L., Podglajen I., Hanras X., Eckert C., Buu-Hoi A., Varon E., Gutmann L.: Relevance of Routine Use of the Anaerobic Blood Culture Bottle. J. Clin. Microbiol.45, 2711–2715 (2007)GrohsP.MainardiJ.L.PodglajenI.HanrasX.EckertC.Buu-HoiA.VaronE.GutmannL.Relevance of Routine Use of the Anaerobic Blood Culture Bottle4527112715200710.1128/JCM.00059-07195126317581942Search in Google Scholar
Hartmeyer G.N., Sóki J., Nagy E., Justesen U.S.: Multidrug-resistant Bacteroides fragilis group on the rise in Europe? J. Med. Microbiol.61, 1784–1788 (2012)HartmeyerG.N.SókiJ.NagyE.JustesenU.S.Multidrug-resistant Bacteroides fragilis group on the rise in Europe?6117841788201210.1099/jmm.0.049825-022956754Search in Google Scholar
Ho P.L., Yau C.Y., Ho L.Y., Lai E.L., Liu M.C., Tse C.W., Chow K.H.: Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method. Anaerobe, 47, 51–56 (2017)HoP.L.YauC.Y.HoL.Y.LaiE.L.LiuM.C.TseC.W.ChowK.H.Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method475156201710.1016/j.anaerobe.2017.04.00528414107Search in Google Scholar
Kaeuffer C., Ruge T., Diancourt L., Romain B., Ruch Y., Jaulhac B., Boyer P.H. First Case of Bacteraemia Due to Carbapenem-Resistant Bacteroides faecis. Antibiotics (Basel). 19, doi: 10.3390/antibiotics10030319 (2021)KaeufferC.RugeT.DiancourtL.RomainB.RuchY.JaulhacB.BoyerP.H.First Case of Bacteraemia Due to Carbapenem-Resistant Bacteroides faecis1910.3390/antibiotics100303192021800348133808699Open DOISearch in Google Scholar
Karlowsky J.A., Walkty A.J., Adam H.J., Baxter M.R., Hoban D.J., Zhanel G.G.: Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010–2011: CANWARD Surveillance Study. Antimicrob. Agents Chemother.56, 1247–1252 (2012)KarlowskyJ.A.WalktyA.J.AdamH.J.BaxterM.R.HobanD.J.ZhanelG.G.Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010–2011: CANWARD Surveillance Study5612471252201210.1128/AAC.05823-11329493922203594Search in Google Scholar
Katsandri A., Papaparaskevas J., Pantazatou A., Petrikkos G.L., Thomopoulos G., Houhoula D.P., Avlamis A.: Two Cases of Infections Due to Multidrug-Resistant Bacteroides fragilis Group Strains. J. Clin. Microbiol.44, 3465–3467 (2006)KatsandriA.PapaparaskevasJ.PantazatouA.PetrikkosG.L.ThomopoulosG.HouhoulaD.P.AvlamisA.Two Cases of Infections Due to Multidrug-Resistant Bacteroides fragilis Group Strains4434653467200610.1128/JCM.00316-06159466616954304Search in Google Scholar
De Keukeleire S., Wybo I., Naessens A., Echahidi F., Van der Beken M., Vandoorslaer K., Vermeulen S., Piérard D.: Anaerobic bacteraemia: A 10-year retrospective epidemiological survey. Anaerobe, 39, 54–59 (2016)De KeukeleireS.WyboI.NaessensA.EchahidiF.Van der BekenM.VandoorslaerK.VermeulenS.PiérardD.Anaerobic bacteraemia: A 10-year retrospective epidemiological survey395459201610.1016/j.anaerobe.2016.02.00926923749Search in Google Scholar
Kierzkowska M., Majewska A., Dobrzaniecka K., Sawicka-Grzelak A., Mlynarczyk A., Chmura A., Durlik M., Deborska-Materkowska D., Paczek L., Mlynarczyk G.: Blood Infections in Patients Treated at Transplantation Wards of a Clinical Hospital in Warsaw. Transplant. Proc.46, 2589–2591 (2014)KierzkowskaM.MajewskaA.DobrzanieckaK.Sawicka-GrzelakA.MlynarczykA.ChmuraA.DurlikM.Deborska-MaterkowskaD.PaczekL.MlynarczykG.Blood Infections in Patients Treated at Transplantation Wards of a Clinical Hospital in Warsaw4625892591201410.1016/j.transproceed.2014.08.02425380873Search in Google Scholar
Kierzkowska M., Majewska A., Mlynarczyk G. Trends and Impact in Antimicrobial Resistance Among Bacteroides and Parabacteroides Species in 2007–2012 Compared to 2013–2017. Microb. Drug Resist.26, 1452–1457 (2020)KierzkowskaM.MajewskaA.MlynarczykG.Trends and Impact in Antimicrobial Resistance Among Bacteroides and Parabacteroides Species in 2007–2012 Compared to 2013–20172614521457202010.1089/mdr.2019.046232407191Search in Google Scholar
Kierzkowska M., Majewska A., Sawicka-Grzelak A., Młynarczyk G.: Pałeczki gram-ujemne beztlenowo rosnące – diagnostyka i znaczenie kliniczne. Post. Mikrobiol.55, 91–98 (2016)KierzkowskaM.MajewskaA.Sawicka-GrzelakA.MłynarczykG.Pałeczki gram-ujemne beztlenowo rosnące – diagnostyka i znaczenie kliniczne5591982016Search in Google Scholar
Kim J., Lee Y., Park Y., Kim M., Choi J.Y., Yong D., Jeong S.H., Lee K.: Anaerobic Bacteraemia: Impact of Inappropriate Therapy on Mortality. Infect. Chemother.48, 91–98 (2016)KimJ.LeeY.ParkY.KimM.ChoiJ.Y.YongD.JeongS.H.LeeK.Anaerobic Bacteraemia: Impact of Inappropriate Therapy on Mortality489198201610.3947/ic.2016.48.2.91494573227433379Search in Google Scholar
Lassmamn B., Gustafson D.R., Wood C.M., Rosenblatt J.E.: Reemergence of anaerobic bacteraemia. Clin. Infect. Dis.44, 895–900 (2007)LassmamnB.GustafsonD.R.WoodC.M.RosenblattJ.E.Reemergence of anaerobic bacteraemia44895900200710.1086/51219717342637Search in Google Scholar
Lee Y., Park Y.J., Kim M.N., Uh Y., Kim M.S., Lee K.: Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. Ann. Lab. Med.35, 479–786 (2015)LeeY.ParkY.J.KimM.N.UhY.KimM.S.LeeK.Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 201235479786201510.3343/alm.2015.35.5.479451049926206683Search in Google Scholar
Löfmark S., Edlund C., Nord Carl E.: Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections. Clin. Infect. Dis.50, (2010)LöfmarkS.EdlundC.Nord CarlE.Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections50201010.1086/64793920067388Search in Google Scholar
Mukhopadhyay S., Puopolo K.M.: Relevance of Neonatal Anaerobic Blood Cultures: New Information for an Old Question. J. Pediatric Infect. Dis. Soc.17, 126–127 (2018)MukhopadhyayS.PuopoloK.M.Relevance of Neonatal Anaerobic Blood Cultures: New Information for an Old Question17126127201810.1093/jpids/pix09529165632Search in Google Scholar
Nagy E.: Anaerobic infections: update on treatment considerations. Drugs, 70, 841–858 (2010)NagyE.Anaerobic infections: update on treatment considerations70841858201010.2165/11534490-000000000-0000020426496Search in Google Scholar
Nagy E., Urbán E.: Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin. Microbiol. Infect.17, 371–379 (2011)NagyE.UrbánE.Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience17371379201110.1111/j.1469-0691.2010.03256.x20456453Search in Google Scholar
Nagy E., Boyanova L., Justesen U.S.: ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin. Microbiol. Infect.24, 1139–1148 (2018)NagyE.BoyanovaL.JustesenU.S.ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories2411391148201810.1016/j.cmi.2018.02.008Search in Google Scholar
Ngo J.T., Parkins M.D., Gregson D.B., Pitout J.D.D., Ross T., Church D.L., Laupland K.B.: Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection, 41, 41–48 (2013)NgoJ.T.ParkinsM.D.GregsonD.B.PitoutJ.D.D.RossT.ChurchD.L.LauplandK.B.Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections414148201310.1007/s15010-012-0389-4Search in Google Scholar
Nguyen M.H., Yu V.L., Morris A.J., McDermott L., Wagener M.W., Harrell L., Snydman D.R.: Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteraemia: Findings of a Multicenter Prospective Observational Trial. Clin. Infect. Dis.30, 870–876 (2000)NguyenM.H.YuV.L.MorrisA.J.McDermottL.WagenerM.W.HarrellL.SnydmanD.R.Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteraemia: Findings of a Multicenter Prospective Observational Trial30870876200010.1086/313805Search in Google Scholar
Ogane K., Maeda T. et al: Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe, 64, doi: 10.1016/j.anaerobe.2020.102215 (2020)OganeK.MaedaT.Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan6410.1016/j.anaerobe.2020.1022152020Open DOISearch in Google Scholar
Patrick S., Duerden B.I.: Non-Sporing Gram-Negative Anaerobes (in) Principles and Practice of Clinical Bacteriology, Second Edition, Eds. Stephen H. Gillespie S.H., Hawkey P.M., John Wiley & Sons, 2006, 541–556PatrickS.DuerdenB.I.Non-Sporing Gram-Negative Anaerobes(in)Second EditionEds.StephenH.GillespieS.H.HawkeyP.M.John Wiley & Sons200654155610.1002/9780470017968.ch45Search in Google Scholar
Philippon A., Slama P., Dény P., Labia R.: A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes. Clin. Microbiol. Rev.29, 29–59 (2016)PhilipponA.SlamaP.DényP.LabiaR.A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes292959201610.1128/CMR.00019-15Search in Google Scholar
Robert R., Deraignac A., Le Moal G., Ragot S., Grollier G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur. J. Clin. Microbiol. Infect. Dis.27, 671–678 (2008)RobertR.DeraignacA.Le MoalG.RagotS.GrollierG.Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia27671678200810.1007/s10096-008-0487-5Search in Google Scholar
Rodloff A.C., Dowzicky M.J.: In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010–2016. Anaerobe, 51, 78–88 (2018)RodloffA.C.DowzickyM.J.In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010–2016517888201810.1016/j.anaerobe.2018.04.009Search in Google Scholar
Rodrigues C., Siciliano R.F., Zeigler R., Strabelli T.M.: Bacteroides fragilis endocarditis: A case report and review of literature. Braz. J. Infect. Dis.16, 100–104 (2012)RodriguesC.SicilianoR.F.ZeiglerR.StrabelliT.M.Bacteroides fragilis endocarditis: A case report and review of literature16100104201210.1016/S1413-8670(12)70285-4Search in Google Scholar
Roh K.H., Kim S., Kim C.K., Yum J.H., Kim M.S., Yong D., Jeong S.H., Lee K., Kim J.M., Chong Y.: New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea. Diagn. Microbiol. Infect. Dis.66, 343–348 (2010)RohK.H.KimS.KimC.K.YumJ.H.KimM.S.YongD.JeongS.H.LeeK.KimJ.M.ChongY.New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea66343348201010.1016/j.diagmicrobio.2009.11.00320226324Search in Google Scholar
Rong S.M.M., Rodloff A.C., Stingu C.S.: Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany. J. Glob. Antimicrob. Resist.24, 328–334 (2021)RongS.M.M.RodloffA.C.StinguC.S.Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany24328334202110.1016/j.jgar.2021.01.00733508481Search in Google Scholar
Sanford Guide: Antibacterial agents: Spectra of Activity, https://webedition.sanfordguide.com/en (01.02.2022)Sanford Guidehttps://webedition.sanfordguide.com/en (01.02.2022)Search in Google Scholar
Schuetz A.N.: Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria. Clin. Infect. Dis.59, 698–705 (2014)SchuetzA.N.Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria59698705201410.1007/978-3-319-78538-7_6Search in Google Scholar
Shafquat Y., Jabeen K., Farooqi J., Mehmood K., Irfan S., Hasan R., Zafar A.: Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan. Antimicrob. Resist. Infect. Control.14, doi: 10.1186/s13756-019-0549-8 (2019)ShafquatY.JabeenK.FarooqiJ.MehmoodK.IrfanS.HasanR.ZafarA.Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan1410.1186/s13756-019-0549-82019656747931210928Open DOISearch in Google Scholar
Sherwood J.E., Fraser S., Citron D.M., Wexler H., Blakely G., Jobling K., Patrick S.: Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe, 17, 152–155 (2011)SherwoodJ.E.FraserS.CitronD.M.WexlerH.BlakelyG.JoblingK.PatrickS.Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan17152155201110.1016/j.anaerobe.2011.02.00721376821Search in Google Scholar
Shimura S., Wada Y. et al: Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area. J. Infect. Chemother.25, 837–844 (2019)ShimuraS.WadaY.Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area25837844201910.1016/j.jiac.2019.07.01831427200Search in Google Scholar
Snydman D.R., Jacobus N.V., McDermott L.A., Goldstein E.J.C., Harrell L., Jenkins S.G., Newton D., Patel R., Hecht D.W.: Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009. Anaerobe, 43, 21–26 (2017)SnydmanD.R.JacobusN.V.McDermottL.A.GoldsteinE.J.C.HarrellL.JenkinsS.G.NewtonD.PatelR.HechtD.W.Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009432126201710.1016/j.anaerobe.2016.11.00327867083Search in Google Scholar
Sóki J.: Extended role for insertion sequence elements in the antibiotic resistance of Bacteroides. World J. Clin. Infect. Dis.3, 1–12 (2013)SókiJ.Extended role for insertion sequence elements in the antibiotic resistance of Bacteroides3112201310.5495/wjcid.v3.i1Search in Google Scholar
Sóki J., Gonzalez S.M., Urban E., Nagy E., Ayala J.A.: Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains. J. Antimicrob. Chemother.66, 2492–500 (2011)SókiJ.GonzalezS.M.UrbanE.NagyE.AyalaJ.A.Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains662492500201110.1093/jac/dkr33921873290Search in Google Scholar
Song Y.L., Liu C.X., McTeague M., Finegold S.M.: “Bacteroides nordii” sp. nov. and “Bacteroides salyersae” sp. nov. Isolated from Clinical Specimens of Human Intestinal Origin. J. Clin. Microbiol.42, 5565–5570 (2004)SongY.L.LiuC.X.McTeagueM.FinegoldS.M.“Bacteroides nordii” sp. nov. and “Bacteroides salyersae” sp. nov. Isolated from Clinical Specimens of Human Intestinal Origin4255655570200410.1128/JCM.42.12.5565-5570.200453527415583282Search in Google Scholar
Snydman D.R., Gorbach S.L. et al: Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007). Clin. Infect. Dis.50, 26–33 (2010)SnydmanD.R.GorbachS.L.Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007)502633201010.1086/64794020067390Search in Google Scholar
Snydman D.R., Hecht D.W. et al: Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009. Anaerobe, 17, 147–151 (2011)SnydmanD.R.HechtD.W.Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–200917147151201110.1016/j.anaerobe.2011.05.014Search in Google Scholar
Tan T.Y., Ng L.S.Y., Kwang L.L., Rao S., Eng L.C.: Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteraemia in an acute care hospital. Anaerobe, 43, 69–74 (2017)TanT.Y.NgL.S.Y.KwangL.L.RaoS.EngL.C.Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteraemia in an acute care hospital436974201710.1016/j.anaerobe.2016.11.009Search in Google Scholar
Toprak N.U., Uzunkaya O.D., Sóki J., Soyletir G.: Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital. Anaerobe,18, 169–171 (2012)ToprakN.U.UzunkayaO.D.SókiJ.SoyletirG.Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital18169171201210.1016/j.anaerobe.2011.10.004Search in Google Scholar
Turner P., Edwards R., Weston V., Ispahani P., Greenwood D., Gazis A.: Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis. The Lancet, 345, 1275–1277 (1995)TurnerP.EdwardsR.WestonV.IspahaniP.GreenwoodD.GazisA.Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis34512751277199510.1016/S0140-6736(95)90927-3Search in Google Scholar
Umemura T., Hamada Y., Yamagishi Y., Suematsu H., Mikamo H.: Clinical characteristics associated with mortality of patients with anaerobic bacteraemia. Anaerobe, 39, 45–50 (2016)UmemuraT.HamadaY.YamagishiY.SuematsuH.MikamoH.Clinical characteristics associated with mortality of patients with anaerobic bacteraemia394550201610.1016/j.anaerobe.2016.02.00726903282Search in Google Scholar
Urbán E.: Five-year retrospective epidemiological survey of anaerobic bacteraemia in a University Hospital and Review of the Literature. Eur. J. Microbiol. Immunol. (Bp). 2, 140–147 (2012)UrbánE.Five-year retrospective epidemiological survey of anaerobic bacteraemia in a University Hospital and Review of the Literature2140147201210.1556/EuJMI.2.2012.2.7395696324672683Search in Google Scholar
Vena A., Muñoz P., Alcalá L., Fernandez-Cruz A., Sanchez C., Valerio M., Bouza E.: Are incidence and epidemiology of anaerobic bacteraemia really changing? Eur. J. Clin. Microbiol. Infect. Dis.34, 1621–1629 (2015)VenaA.MuñozP.AlcaláL.Fernandez-CruzA.SanchezC.ValerioM.BouzaE.Are incidence and epidemiology of anaerobic bacteraemia really changing?3416211629201510.1007/s10096-015-2397-726017663Search in Google Scholar
Wang F.D., Liao C.H., Lin Y.T., Sheng W.H., Hsueh P.R.: Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis.33, 2041–2052 (2014)WangF.D.LiaoC.H.LinY.T.ShengW.H.HsuehP.R.Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan3320412052201410.1007/s10096-014-2175-y24930042Search in Google Scholar
Wareham D.W., Wilks M., Ahmed D., Brazier J.S., Millar M.: Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy. Clin. Infect. Dis.40, 67–68 (2005)WarehamD.W.WilksM.AhmedD.BrazierJ.S.MillarM.Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy406768200510.1086/428623Search in Google Scholar
Wexler H.M.: Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clin. Microbiol. Rev.20, 593–621 (2007)WexlerH.M.Bacteroides: the Good, the Bad, and the Nitty-Gritty20593621200710.1128/CMR.00008-07217604517934076Search in Google Scholar
Wexler H.M.: The Genus Bacteroides (in) The Prokaryotes, eds. Rosenberg E., DeLong E.F., Lory S., Stackebrandt E., Thompson F., Springer, Berlin, 2014, 459–484WexlerH.M.The Genus Bacteroides(in)eds.RosenbergE.DeLongE.F.LoryS.StackebrandtE.ThompsonF.SpringerBerlin201445948410.1007/978-3-642-38954-2_129Search in Google Scholar
Yarbrough M.L., Wallace M.A., Burnham C.D.: Comparision of microorganism detection and time to positivity in pediatric and standard media from three major commercial continuously monitored blood culture systems. J. Clin. Microbiol.59, e00429–21 (2021)YarbroughM.L.WallaceM.A.BurnhamC.D.Comparision of microorganism detection and time to positivity in pediatric and standard media from three major commercial continuously monitored blood culture systems59e0042921202110.1128/JCM.00429-21Search in Google Scholar
Yoshino Y., Kitazawa T., Ikeda M., Tatsuno K., Yanagimoto S., Okugawa S., Ota Y., Yotsuyanagi H.: Clinical features of Bacteroides bacteraemia and their association with colorectal carcinoma. Infection, 40, 63–67 (2012)YoshinoY.KitazawaT.IkedaM.TatsunoK.YanagimotoS.OkugawaS.OtaY.YotsuyanagiH.Clinical features of Bacteroides bacteraemia and their association with colorectal carcinoma406367201210.1007/s15010-011-0159-821773761Search in Google Scholar
Zafar H., Saier M.H. Jr. Gut Bacteroides species in health and disease. Gut Microbes, 13, 1–20 (2021)ZafarH.SaierM.H.Jr.Gut Bacteroides species in health and disease13120202110.1080/19490976.2020.1848158787203033535896Search in Google Scholar
Zahar J.R., Farhat H., Chachaty E., Meshaka P., Antoun S., Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin. Microbiol. Infect.11, 724–729 (2005)ZaharJ.R.FarhatH.ChachatyE.MeshakaP.AntounS.NitenbergG.Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study11724729200510.1111/j.1469-0691.2005.01214.x16104987Search in Google Scholar